Search

Your search keyword '"A. Boucly"' showing total 951 results

Search Constraints

Start Over You searched for: Author "A. Boucly" Remove constraint Author: "A. Boucly"
951 results on '"A. Boucly"'

Search Results

1. Direct observation of the complex S(IV) equilibria at the liquid-vapor interface

4. Evidence and unresolved questions in pulmonary hypertension: Insights from the 5th French Pulmonary Hypertension Network Meeting

5. Immunovirological status in people with perinatal and adult-acquired HIV-1 infection: a multi-cohort analysis from FranceResearch in context

6. Immunovirological status in people with perinatal and adult-acquired HIV-1 infection: a multi-cohort analysis from France

8. ERS International Congress 2023: highlights from the Pulmonary Vascular Diseases Assembly

9. Pulmonary veno-occlusive disease: illustrative cases and literature review

10. Outcomes and risk assessment in pulmonary veno-occlusive disease

13. Real‐world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real‐world Evidence Working Group

14. Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial

19. Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension

20. Functional respiratory complaints among COVID-19 survivors: a prospective cohort study

21. Germanium surface segregation in highly doped Ge:β-Ga2O3 grown by molecular beam epitaxy observed by synchrotron radiation hard x-ray photoelectron spectroscopy.

25. Behavioural disinhibition in frontotemporal dementia investigated within an ecological framework

27. Pulmonary Hypertension in Patients with Common Variable Immunodeficiency

28. Role of Exercise Hemodynamics in the Prediction of Pulmonary Arterial Hypertension in BMPR2Mutation Carriers

31. Respiratory symptoms and radiological findings in post-acute COVID-19 syndrome

34. Survival Improved in Patients Aged ≤ 70 Years With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension During the Period 2006 to 2017 in France

37. Are the PAH risk stratification tools useful in post-capillary pulmonary hypertension? Insights from the PH-HF study

38. Évolution de l’incidence de l’hypertension artérielle pulmonaire (HTAP) chez les patients suivis pour une infection par le VIH au cours des 15 dernières années

39. Suivi des patients atteints d’hypertension artérielle pulmonaire avec vasoréactivité en aigu et traités par inhibiteurs calciques : facteurs de risque d’échappement au traitement

45. Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society

47. ERS International Congress 2023: highlights from the Pulmonary Vascular Diseases Assembly

48. Supplementary Figure S1 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer

49. Supplementary Table S2 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer

50. Data from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer

Catalog

Books, media, physical & digital resources